Human Vasodilatory Effect of GLP-1

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm and coronary arteries

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Papworth Hospital NHS Foundation Trust
• Treatments: Glucagon-Like Peptide 1

Criteria

Inclusion Criteria:

• Waiting list for elective PCI to LAD Able to give informed consent Over 18

Exclusion Criteria:

• GLP-1 based therapy Insulin Calcium channel blockers Nicorandil Nitrates